Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2023 Jan 1.

Published in final edited form as: Br J Haematol. 2021 Sep 27;196(1):169–178. doi: 10.1111/bjh.17840

Figure 2. — (A) Cumulative Incidence of aGVHD (grade III-IV) in MRD/URD (Tacro/MTX) recipients, MRD/URD (PT/Cy), HRD (PT/Cy). (B) Cumulative Incidence of moderate/severe cGVHD in MRD/URD (Tacro/MTX), MRD/URD (PT/Cy), HRD (PT/Cy) recipients.

Figure 2. — (A) Cumulative Incidence of aGVHD (grade III-IV) in MRD/URD (Tacro/MTX) recipients, MRD/URD (PT/Cy), HRD (PT/Cy). (B) Cumulative Incidence of moderate/severe cGVHD in MRD/URD (Tacro/MTX), MRD/URD (PT/Cy), HRD (PT/Cy) recipients.